Overview |
bs-9202R-APC-Cy5 |
CD300A/C Polyclonal Antibody, APC-Cy5 Conjugated |
WB, IF(IHC-P) |
Human |
Specifications |
APC-Cy5 |
Rabbit |
KLH conjugated synthetic peptide derived from human CD300A |
41-140/299 |
Polyclonal |
IgG |
1ug/ul |
Purified by Protein A. |
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
Target |
11314 |
Q9UGN4 |
Extracellular, Membrane bound |
CD300A; CMRF35-like molecule 8; CLM-8; CD300 antigen-like family member A; CMRF-35-H9; CMRF35-H9; IRC1/IRC2; Immunoglobulin superfamily member 12;
IgSF12; Inhibitory receptor protein 60; IRp60; NK inhibitory receptor; CMRF35H; CD300C; CMRF35-like molecule 6; CLM-6; CD300 antigen-like family member C; CMRF35-A1; CMRF-35; Immunoglobulin superfamily member 16; IgSF16; CMRF35A1 |
Inhibitory receptor which may contribute to the down-regulation of cytolytic activity in natural killer (NK) cells, and to the down-regulation of mast cell degranulation. |
Application Dilution |
WB |
1:300-5000 |
IF(IHC-P) |
1:50-200 |